The Recall Desk
SevereFDA (Devices)·Z-0728-2021·Announced 2021-01-20

Boston Scientific Recalls Lotus Edge Valve Systems Due to Deployment Failure Risk

Boston Scientific is recalling 219 Lotus Edge Valve Systems because a visual inspection error could prevent the delivery system from releasing during deployment.

What this means for you

Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The recall involves a structural defect in a critical medical device (transcatheter aortic valve) that could prevent the delivery system from releasing, which aligns with the rubric criterion for 'structural vehicle defect' or significant injury risk in high-risk medical devices, warranting a Severe classification.

Plain-English summary

Boston Scientific Corporation is recalling 219 units of the Lotus Edge Valve System, a transcatheter aortic valve prosthesis premounted on a delivery system. The affected devices are 23mm, sterile, and identified by REF H749LVSUS230 and GTIN 08714729960904. The recall covers all unexpired lot numbers with expiration dates ranging from November 2, 2020, to October 29, 2021.

The recall was initiated because failure to execute the visual inspection correctly prior to locking the valve during the deployment process can lead to the inability to release the delivery system. This defect poses a risk to patients undergoing the procedure, as the device may not function as intended during deployment.

Distribution of the affected devices was made to numerous U.S. states, including Alabama, Arkansas, Arizona, California, Colorado, the District of Columbia, Delaware, Florida, Georgia, Iowa, Idaho, Illinois, Indiana, Kansas, Louisiana, Massachusetts, Maryland, Michigan, Minnesota, Missouri, North Carolina, North Dakota, New Jersey, New Mexico, Nevada, New York, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, Tennessee, Texas, Utah, Virginia, Washington, Wisconsin, and West Virginia. Government distribution was also made. Additionally, foreign distribution occurred in Australia, Austria, Belgium, Canada, the Czech Republic, Denmark, Finland, France, Germany, Great Britain, Ireland, Italy, Japan, Luxembourg, the Netherlands, Norway, Poland, Portugal, South Korea, Spain, Sweden, and Switzerland. Healthcare providers and patients should contact Boston Scientific for further instructions on managing the recalled devices.

The recalled product

Product
Lotus Edge Valve System, Transcatheter Aortic Valve Prosthesis Premounted on Delivery System, 23mm, sterile, REF H749LVSUS230, GTIN 08714729960904
Manufacturer
Boston Scientific Corporation
Category
Medical Device — Cardiovascular
Hazard
Affected units
219

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • GTIN 08714729960904. All unexpired lot numbers
  • expiration dates 2-Nov-2020 through 29-Oct-2021

Distribution

Distributed in 38 states:

Part of a larger recall action

This product is one of 6 recalled by Boston Scientific Corporation under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 6 products in this recall →

Related recalls

Same manufacturer · Boston Scientific Corporation

See all →

Same hazard · deployment failure

See all →